The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.00
Bid: 14.50
Ask: 15.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.448%)
Open: 14.00
High: 0.00
Low: 0.00
Prev. Close: 14.00
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on refinancing and current trading

17 Aug 2020 07:00

RNS Number : 2539W
Carclo plc
17 August 2020
 

Carclo plc

 

("Carclo" or "the Group" or "the Company")

 

Update on refinancing and current trading

 

 

Tripartite financing agreement secured

 

The Board announces that on 14 August 2020, the Group agreed revised funding arrangements with the Company's main secured creditors, HSBC and the Pension Scheme, which provide access to ongoing bank facilities as well as visibility over repayment schedules through to July 2023.

 

As part of this agreement, new facilities have been entered into with the Group's lending bank, HSBC, which comprise a Term Loan of £34.5m and a Revolving Credit Facility of £3.5m. In parallel to this, the Group reached agreement with the Trustees of the Pension Scheme in respect of both the actuarial deficit and the resultant deficit repair contributions to be made over the next three years; £2.8m (2021), £3.9m (2022) and £3.8m (2023).

 

As previously announced, securing a suitable long-term funding position for the Group has been a key focus of the Board. With a more stable base now established, the Board can turn its focus to delivering its growth strategy aimed at capturing the significant long-term opportunities it sees for the Group.

 

Update on current trading

 

Group revenue for the continuing businesses for the first quarter was 12% lower than the same period last year. In anticipation of a material reduction in activity in both businesses during the first quarter, the Group implemented a number of operating and commercial initiatives aimed at preserving operational continuity as well as matching cost to reduced demand. The Group has also been able to access Covid-19 relief schemes, particularly in relation to job retention programmes, in a number of its territories including for the UK and US operations. As a result of an effective response by the business, and more resilient demand conditions in certain segments, the overall trading performance in the first quarter of the Group's current financial year to 31 March 2021 was ahead of the Board's initial, Covid-19 adjusted, planning assumptions with both the Technical Plastics and Aerospace divisions recording encouraging performances. Group net debt excluding IFRS16 lease liabilities as at 27 June 2020 was £24.2m (31 March 2020: £22.1m).

 

The Technical Plastics business benefited from robust demand for products relating to Covid-19 testing, which partially offset a reduction in demand for other products in both the medical diagnostics and industrial sectors that had been exacerbated by the impact of government-imposed lockdown of a customer's facility in India. The business was also successful in securing a number of new tooling orders in the medical diagnostics sector which are expected to deliver significant production volumes in future years.

 

The Aerospace Division performed better than anticipated in the first quarter, largely as a result of continued offtake from the existing orderbook, which partly offset the impact of a significant reduction in both newbuild and spares demand from Airbus.

 

Outlook

 

In light of the ongoing uncertainty presented by the pandemic, as well as any wider resultant economic impacts, the Board does not believe that it is possible to provide detailed guidance for the year ending 31 March 2021 at this time. Activity levels in July were broadly in line with those seen in the first quarter and the Board remains cautious about market conditions in the near term. The Group will continue to take action to reduce its cost base, where appropriate, to mitigate the effect of any reduction in demand, whilst seeking to preserve the capability and capacity to respond positively as conditions improve.

 

The Board expects to release the Group's preliminary results on 25 August 2020.

 

Enquiries:

 

FTI Consulting 020 3727 1340

Nick Hasell / Susanne Yule

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKKABKDBKBAFD
Date   Source Headline
10th Feb 20164:36 pmRNSPrice Monitoring Extension
4th Feb 20167:00 amRNSInterim Management Statement
17th Nov 20157:00 amRNSHalf Yearly Report
16th Oct 20153:58 pmRNSHolding(s) in Company
15th Oct 20157:00 amRNSHalf Year Trading Update
4th Sep 201510:20 amRNSResult of AGM
3rd Sep 20157:00 amRNSAGM Statement
15th Jul 20157:00 amRNSPerformance Share Plan
10th Jul 20153:37 pmRNSHolding(s) in Company
12th Jun 20159:59 amRNSHolding(s) in Company
10th Jun 20153:18 pmRNSDirector/PDMR Shareholding
9th Jun 20157:00 amRNSFinal Results
1st Jun 20157:00 amRNSHolding(s) in Company
17th Apr 20157:00 amRNSAnnouncement of CIT Technology Licensing Agreement
9th Apr 20157:00 amRNSYear End Trading Update
1st Apr 20157:00 amRNSDirectorate Change
31st Mar 20157:00 amRNSRefinancing
26th Mar 20157:00 amRNSDirectorate Change
19th Mar 20157:00 amRNSCourt confirms Capital Reduction
11th Mar 20154:41 pmRNSHolding(s) in Company
25th Feb 20153:50 pmRNSResult of General Meeting
11th Feb 20153:02 pmRNSHolding(s) in Company
10th Feb 201512:09 pmRNSHolding(s) in Company
10th Feb 20159:41 amRNSHolding(s) in Company
9th Feb 20157:00 amRNSNotice of General Meeting
5th Feb 20157:00 amRNSInterim Management Statement
22nd Dec 20144:37 pmRNSHolding(s) in Company
12th Dec 201411:59 amRNSHolding(s) in Company
18th Nov 20147:00 amRNSAppointment of Corporate Broker
18th Nov 20147:00 amRNSHalf Yearly Report
10th Oct 20147:00 amRNSHalf Year Trading Update
4th Sep 20143:30 pmRNSResult of AGM
14th Aug 20147:00 amRNSInterim Management Statement
7th Aug 20147:00 amRNSAtmel Corporation Announcement
14th Jul 20147:00 amRNSPerformance Share Plan
18th Jun 20147:00 amRNSDirector/PDMR Shareholding
12th Jun 201410:14 amRNSHolding(s) in Company
10th Jun 20147:00 amRNSFinal Results
1st May 20147:00 amRNSAtmel Corporation and Trading Update
9th Apr 20142:10 pmRNSHolding(s) in Company
7th Apr 20147:00 amRNSYear End Trading Update
3rd Apr 20143:38 pmRNSCIT settlement of Litigation with Uni-Pixel
6th Feb 20142:40 pmRNSDirector/PDMR Shareholding
6th Feb 20147:00 amRNSAtmel Corporation Announcement
22nd Jan 20147:00 amRNSInterim Management Statement
19th Nov 20137:00 amRNSHalf Yearly Report
5th Nov 20132:00 pmRNSBlocklisting Interim Review
31st Oct 20137:00 amRNSAtmel Corporation Announcement
10th Oct 20137:00 amRNSHalf Year Trading Update
30th Sep 20134:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.